RecruitingNot ApplicableNCT07023185

Cold and Compression Post TKA

Cold and Compression After Total Knee Arthroplasty for Pain Attenuation: A Randomized, Controlled Trial


Sponsor

Ochsner Health System

Enrollment

90 participants

Start Date

Dec 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare pain score (Patient-Reported Outcomes Measurement Information System: PROMIS NRS Pain Subscale) between the control and cold/compression groups pre-surgically, daily after surgery for 14 days, then weekly after surgery for 3 months, and at 6 months post-surgery.


Eligibility

Min Age: 50 Years

Inclusion Criteria5

  • Aged 50 yr or older
  • Patient of Dr. Howard Hirsch or Dr. Vinod Dasa scheduled for total knee arthroplasty (knee replacement) at Ochsner Kenner
  • Will receive outpatient physical therapy at OTW Driftwood for the entire post-op rehabilitation period
  • English speaking
  • Diagnosis of primary osteoarthritis

Exclusion Criteria48

  • Chronic opioid use
  • Opioid use within the last 3 months
  • PCS score ≥ 30
  • Diagnosis of inflammatory disease process (i.e., gout, rheumatoid arthritis, systematic lupus erythematosus...)
  • Discharge to skilled nursing
  • Cold intolerance related to diseases, like Raynaud's
  • Significant vascular impairment in the affected region
  • Current clinical signs of inflammatory phlebitis, venous ulcers, or cellulitis
  • Significant risk factors or current clinical signs of embolism (e.g., pulmonary embolus, pulmonary edema, cerebral infarction, atrial fibrillation, endocarditis, myocardial infarction, or atheromatous embolic plaque)
  • A condition in which increased venous or lymphatic return is not desired in the affected extremity (e.g., lymphedema after breast cancer or other local carcinoma and/or carcinoma metastasis in the affected extremity).
  • Uncontrolled hypertension (physician discretion), cardiac failure, extreme low blood pressure, or decompensated cardiac insufficiency.
  • Localized unstable skin condition (e.g., dermatitis, vein ligation, gangrene, or recent skin graft) in the affected region.
  • Had recent toe surgery in the affected region
  • Current clinical signs in the affected region of significant peripheral edema (e.g., deep vein thrombosis, chronic venous insufficiency, acute compartment syndrome, systemic venous hypertension, congestive heart failure, cirrhosis/liver failure, renal failure).
  • An acute, unstable (untreated) fracture in the affected region.
  • Any active local or systemic infection.
  • Obtunded or with diabetes mellitus, multiple sclerosis, poor circulation, spinal cord injuries, and rheumatoid arthritis
  • Areas of skin breakdown or damage (damaged or at-risk skin) producing uneven heat conduction across the skin (e.g., open wound, scar tissue, burn or skin graft). Any open wound must be dressed prior to use of the Polar Care Wave System.
  • Presumptive evidence of congestive heart failure
  • Pre-existing DVT condition
  • Deep acute venal thrombosis (Phlebothrombosis)
  • Episodes of pulmonary embolism
  • Pulmonary edema
  • Acute inflammation of the veins (Thrombophlebitis)
  • Decompensated cardiac insufficiency
  • Arterial dysregulation
  • Erysipelas
  • Carcinoma and carcinoma metastasis in the affected extremity
  • Decompensated hypertonia
  • Acute inflammatory skin diseases or infection
  • Venous or arterial occlusive disease
  • Medical situations where increased venous or lymphatic return is undesirable
  • Poor peripheral circulation
  • Severe arteriosclerosis, or active infection
  • Known hematological dyscrasias that predispose to thrombosis (e.g., paroxysmal cold hemoglobinuria, cryoglobulinemia, sicklecell disease, serum cold agglutinins).
  • Tissues inflamed as a result of recent injury or exacerbation of chronic inflammatory condition.
  • Compromised local circulation or neurologic impairment (including paralysis or localized compromise due to multiple surgical procedures or diabetes) in the affected region.
  • Cognition or communication impairments that prevent them from giving accurate and timely feedback.
  • Cold allergy
  • Cold agglutinin disorders like paroxysmal cold hemoglobinuria
  • Buerger's disease
  • Chilblains
  • Cryoglobulinemia
  • Sickle cell anemia
  • Uncontrolled diabetes (physician discretion)
  • Hypersensitivity to cold
  • History of cold injury
  • Severe cardiovascular disease, anesthetic skin, hypercoagulation disorders, poor circulation, extremities sensitive to pain, extremely low blood pressure that are incapacitated, decreased skin sensitivity, vein ligation or recent skin grafts, or pheochromocytoma.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECold and Compression

External mechanical compression therapy (e.g., compression stockings) has been shown to reduce swelling and risk of deep vein thrombosis in the lower limbs following TKA.12,13 Combining advanced cryotherapy (continuous circulating cold flow) and dynamic compression may offer added benefits than either traditional cryotherapy (e.g., cold packs) or compression (e.g., stockings) alone.

OTHERSOC (Standard of care)

Patients enrolled in this arm will be discharged with 28 hydrocodone/APAP 7.5 mg pills taken every 6 hours as needed (or its MME equivalent), 1 identical refill if patient calls, and cold therapy (bag of ice or gel pack)


Locations(1)

Ochsner Medical Center - Kenner

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07023185